The Summit for Clinical Ops Executives – also known as the SCOPE Summit – takes place in Orlando, Florida 12-15 of February. It’s the 9th year for the conference, which is one of the most renowned in the industry, and for the first time, Trialbee is attending.
– We are very excited to attend the SCOPE Summit. It is a great platform for us to connect with industry leaders and participate in discussions about the future of clinical trial management, says Max Westling, Sr. Dir. BD & Strategy, who is attending the summit with Kyle Flickinger, Sr. Dir. BD & Customer Solutions.
As Trialbee continue to expand their presence in the American market, attending the SCOPE Summit marks an important step towards creating more brand awareness about the company’s innovative product offerings in the United States.
– Our mission to create a holistic digitalization of clinical trial management will ultimately benefit all stakeholders in medical research, explains Max Westling, and continues:
– Moreover, we see a need to bring medical research and healthcare closer to each other in order to reduce delays in drug development and bring cutting-edge treatments to patients more quickly.